<DOC>
	<DOCNO>NCT00797017</DOCNO>
	<brief_summary>The purpose observational study investigate impact fentanyl matrix improvement pain function spinal disorder-related chronic pain .</brief_summary>
	<brief_title>Study Impact Fentanyl Matrix Improvement Pain Functioning Spinal Disorder-related Pain</brief_title>
	<detailed_description>This study prospective , open-label , non-interventional study . The objective study investigate impact fentanyl matrix improvement pain function 8-week treatment fentanyl matrix patient complain spinal disorder-related chronic pain clinical practice accord investigator 's discretion . The primary endpoint percent pain intensity difference baseline week 8 study . Each patient evaluate pain intensity every 28 day 8 week . The secondary objective observe change follow variable administrate fentanyl matrix ; K-ODI ( Korean version - Oswestry Disability Index ) score , sleep disturbance , disturbance activity daily live disturbance social activity . In addition , Investigator patient global assessment , patient preference , CGI-I ( Clinical Global Impression - Improvement ) Adverse Events investigate . LDK : Lumbar degenerative kyphosis , CRPS : Complex Regional Pain SYndrome , FBSS : Failed Back Surgery Syndrome Observational Study - No investigational drug administer</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Spinal Diseases</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Patients complain spinal disorderrelated chronic pain persist 3 month long Patients fully observe overall clinical study requirement include KODI completion investigator 's discretion Patients complain severe pain ( NRS score = 7 ) pain treat enough previous analgesic Patients never administer fentanyl matrix last one month Patients history drug alcohol abuse past Childbearing woman pregnant likely pregnant study period male patient neither infertile willing refrain sexual relation whose partner conduct effective contraception ( implant , injection , oral contraceptive , intrauterine device , etc . ) Patients unable use transdermal system due skin disease Patients serious mental disorder Patients history hypersensitivity opioid analgesic Patients history CO2 retention Patients eligible study participation base warning , precaution contra medication package insert study drug investigator 's discretion</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Chronic Pain</keyword>
	<keyword>Fentanyl Matrix</keyword>
	<keyword>Spinal disorder-related pain</keyword>
</DOC>